SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...
Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...
There is no single test to diagnose motor neurone disease. So it is generally only through referral to a neurologist, then ...
Higher comorbidity burden, uveitis, and psoriasis are independently associated with accelerated spinal radiographic ...